All this information that is being generated on the molecular and pharmacodynamic mechanisms leads us to see the need to create multidisciplinary investigative groups for the development of hepatoprotectors or hepatic antioxidants
95% of children exposed by 9 months Neurodevelopmental disorder prevalence: 1960s: 1 in 10,000 1980s: 1 in 2,000 Late 1990s: 1 in 200 2021: 1 in 44 1996-2010: 269% increase in prevalence 1998-2018: 787% increase in UK The dramatic rise began in the late 1980s and accelerated through the 1990s and 2000sapproximately 25-30 years after acetaminophen's widespread adoption in pregnancy
10, 2022 from Sepah, Y., Samad, L., Altaf, A., et al
The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form
Yang C, Ko B, Hensley CT, Jiang L, Wasti AT, Kim J, et al